Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Pharmaceutical Stocks To Watch Now - February 3rd - Markets Daily
Abbott CEO Share Purchase Highlights $21b Exact Sciences Deal And Valuation
Sollinda Capital Management LLC Sells 15,866 Shares of Abbott Laboratories $ABT
Jones Financial Companies Lllp Buys 61,627 Shares of Abbott Laboratories $ABT
Abbott Laboratories $ABT Stake Lessened by Thrivent Financial for Lutherans
Abbott Labs CEO makes $2M bet as stock sinks
Abbott Laboratories (ABT): A Bull Case Theory - Insider Monkey
Why Abbott Labs CEO Robert Ford is betting $2M on ABT dip | ABT
Best Pharmaceutical Stocks To Watch Today - February 1st - Markets Daily
Barclays Lowers Abbott Laboratories (NYSE:ABT) Price Target to $142.00 - Markets Daily
Abbott Laboratories (NYSE:ABT) Price Target Cut to $142.00 by Analysts at Barclays - Stock Observer
Medical Stocks To Keep An Eye On - February 1st - Markets Daily
Top Pharmaceutical Stocks To Add to Your Watchlist - January 31st - Markets Daily
Principal Financial Group Inc. Sells 331,362 Shares of Abbott Laboratories $ABT
Freedom Capital Upgrades Abbott Laboratories (ABT) to Buy
Abbott Laboratories (NYSE:ABT) Given New $119.00 Price Target at Leerink Partners - Markets Daily
Daiwa Capital Markets Has Lowered Expectations for Abbott Laboratories (NYSE:ABT) Stock Price
Abbott Laboratories (NYSE:ABT) Rating Increased to Strong-Buy at Freedom Capital
Private Wealth Partners LLC Purchases 12,025 Shares of Abbott Laboratories $ABT
Abbott Laboratories (NYSE:ABT) Price Target Lowered to $113.00 at Daiwa Capital Markets - Stock Observer
Summit Global Investments Lowers Stock Holdings in Abbott Laboratories $ABT
Abbott Laboratories (NYSE:ABT) Raised to "Strong-Buy" at Freedom Capital - Stock Observer
Best Medical Stocks To Research - January 28th - Stock Observer
AE Wealth Management LLC Raises Stock Holdings in Abbott Laboratories $ABT
Abbott Laboratories (NYSE:ABT) Price Target Cut to $119.00 by Analysts at Leerink Partners - Daily Political
Abbott Resets Nutrition While Expanding Diagnostics And Device Growth Drivers
National Pension Service Has $477.60 Million Position in Abbott Laboratories $ABT - Daily Political
Medical Stocks To Watch Today - January 30th
Decent Organic Sales Growth Expected for Abbott Laboratories (ABT) in 2026
This beaten-down sector could offer you a ripe investment opportunity | Morningstar
Everett Harris & Co. CA Trims Stock Position in Abbott Laboratories $ABT
Townsquare Capital LLC Sells 17,856 Shares of Abbott Laboratories $ABT - Daily Political
Great Lakes Advisors LLC Has $179.83 Million Holdings in Abbott Laboratories $ABT
New York State Common Retirement Fund Decreases Stake in Abbott Laboratories $ABT
Abbott Laboratories $ABT Shares Bought by Mirae Asset Global Investments Co. Ltd. - Daily Political
How New Price Targets Are Shaping The Evolving Story For Abbott Laboratories (ABT)
Cardiovascular Surgical Devices Market Competitive Analysis Report 2025: Key Players, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts
Abbott Laboratories (NYSE:ABT) Given New $140.00 Price Target at Argus - Markets Daily
Abbot (ABT) is a High Quality Company, Says Jim Cramer
Abbott Laboratories (NYSE:ABT) Price Target Lowered to $140.00 at Argus - Stock Observer
Abbott Laboratories $ABT Shares Sold by Bank of New York Mellon Corp
Abbott Laboratories $ABT Holdings Cut by Truist Financial Corp - Stock Observer
Phoenix Financial Ltd. Sells 7,773 Shares of Abbott Laboratories $ABT - Daily Political
What To Expect From Stryker's (SYK) Q4 Earnings
Is Abbott (ABT) Insider Buying Offsetting Concerns Around Nutrition and Diagnostics Earnings Pressure?
Lbp Am Sa Boosts Stock Holdings in Abbott Laboratories $ABT
Abbott Laboratories (NYSE:ABT) Receives $140.79 Consensus PT from Brokerages - Daily Political
Abbott Reworks Nutrition While Targeting Cancer Diagnostics With Exact Sciences Deal
Evercore ISI Says Abbott's (ABT) Core Growth Drivers Are Still Intact
Top Pharmaceutical Stocks To Keep An Eye On - January 26th - Markets Daily
Hedge Fund and Insider Trading News: Ken Griffin, Bill Ackman, Mala Gaonkar, Millennium Management, Berkshire Hathaway, Abbott Laboratories (ABT), GameStop Corp (GME), and More
Milk Powder Market Report 2026: Industry Forecast to Reach $6.19 Billion by 2030, Driven Rising Demand for Shelf-Stable Dairy Products in Regions with Limited Cold-Chain Infrastructure
Parthenon LLC Has $2.91 Million Position in Abbott Laboratories $ABT - Stock Observer
Abbott Laboratories $ABT Shares Sold by Trek Financial LLC - Stock Observer
Piper Sandler Cuts Abbott Laboratories (NYSE:ABT) Price Target to $135.00 - Daily Political
Abbott Laboratories $ABT Shares Sold by TrueMark Investments LLC - Stock Observer
Medical Stocks Worth Watching - January 24th - Markets Daily
Analysts Conflicted on These Healthcare Names: Intuitive Surgical (ISRG) and Abbott Laboratories (ABT) | Markets Insider
Abbott Laboratories (NYSE:ABT) Shares Gap Down - What's Next? - Markets Daily
Abbott Laboratories $ABT Shares Purchased by Mitsubishi UFJ Trust & Banking Corp
Abbott Laboratories (ABT) Margin Compression Challenges Steady Compounder Narrative After FY 2025 Results
UniSuper Management Pty Ltd Buys 44,239 Shares of Abbott Laboratories $ABT - Stock Observer
Mn Services Vermogensbeheer B.V. Acquires 9,900 Shares of Abbott Laboratories $ABT - Daily Political
Abbott Laboratories (NYSE:ABT) Receives Consensus Rating of "Moderate Buy" from Brokerages
Abbott Laboratories $ABT Shares Sold by Gibbs Wealth Management - Daily Political
Abbott Laboratories (NYSE:ABT) Issues Q1 2026 Earnings Guidance - Daily Political
Assessing Abbott Laboratories (ABT) Valuation After Q4 2025 Earnings Miss And Softer 2026 Guidance
Citigroup Cuts Abbott Laboratories (NYSE:ABT) Price Target to $140.00
Best Medical Stocks To Keep An Eye On - January 23rd - Markets Daily
The Goldman Sachs Group Cuts Abbott Laboratories (NYSE:ABT) Price Target to $140.00 - Markets Daily
Abbott Laboratories (NYSE:ABT) Price Target Cut to $135.00 by Analysts at Royal Bank Of Canada - Markets Daily
Contrasting Abbott Laboratories (NYSE:ABT) & DiaSorin (OTCMKTS:DSRLF)
Sanford C. Bernstein Lowers Abbott Laboratories (NYSE:ABT) Price Target to $125.00
Abbott Faces Near-Term Headwinds in Nutrition and Slower Long-Term Libre Growth | Morningstar
Abbott Laboratories (NYSE:ABT) Price Target Cut to $132.00 by Analysts at Oppenheimer
Abbott Laboratories (NYSE:ABT) Given New $130.00 Price Target at Raymond James Financial
Abbott Laboratories (NYSE:ABT) Price Target Lowered to $135.00 at Royal Bank Of Canada
Evercore ISI Issues Pessimistic Forecast for Abbott Laboratories (NYSE:ABT) Stock Price
Abbott Laboratories (NYSE:ABT) Price Target Cut to $135.00 by Analysts at Piper Sandler - Markets Daily
Abbott Laboratories (NYSE:ABT) Given New $140.00 Price Target at BTIG Research - Markets Daily
Piper Sandler Issues Pessimistic Forecast for Abbott Laboratories (NYSE:ABT) Stock Price
Abbott Laboratories (NYSE:ABT) Price Target Cut to $140.00 by Analysts at BTIG Research
Abbott Laboratories (NYSE:ABT) Q4 2025 Earnings Call Transcript
NVE Corporation (NASDAQ:NVEC) Q3 2026 Earnings Call Transcript
The Goldman Sachs Group Has Lowered Expectations for Abbott Laboratories (NYSE:ABT) Stock Price - Stock Observer
Latest news
Show moreZelenskyy Expresses Doubts About Budapest as Venue for Ukraine Peace Talks
Europe Rallies Behind Ukraine Amid Trump Pressure, Eyes Frozen Russian Assets
Gold Price Surge Fueled by Fed Rate Cut Expectations and Economic Uncertainty
